Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review

Anti-anaplastic lymphoma kinase (ALK)-targeted therapy dramatically improves therapeutic responses in patients with ALK-rearranged lung adenocarcinoma (Ad-LC). A few cases of squamous cell lung carcinoma (Sq-LC) with ALK rearrangement have been reported; however, the clinicopathological features and...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Junko, Togo, Shinsaku, Sumiyoshi, Issei, Namba, Yukiko, Suina, Kentaro, Mizuno, Takafumi, Kadoya, Kotaro, Motomura, Hiroaki, Iwai, Moe, Nagaoka, Tetsutaro, Sasaki, Shinichi, Hayashi, Takuo, Uekusa, Toshimasa, Abe, Kanae, Urata, Yasuo, Sakurai, Fuminori, Mizuguchi, Hiroyuki, Kato, Shunsuke, Takahashi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963613/
https://www.ncbi.nlm.nih.gov/pubmed/29844868
http://dx.doi.org/10.18632/oncotarget.25257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963613/
https://www.ncbi.nlm.nih.gov/pubmed/29844868
http://dx.doi.org/10.18632/oncotarget.25257

Ejemplares similares